A0Q2B3 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibkk2tbieuwc4bxhq6g6342ygjkxezr7om5fav2sf6tjymqtpgyya/metadata.json
IPFS of structure file: 
bafybeifzpfdnchyzaqg5o75sxv3cwsy7xrw3rmjhh2ndvq6drkeli4xv6m/AF-A0Q2B3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd34DD3DBbC95510c872aD7e41A651f650Bd07472
First NFT owner address (bech32): 
genesis16dxa8kauj4gsepe26ljp5eglv59aqarjgujxfw
Current NFT ID #166554 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166554
Accession (UniProt):
A0Q2B3
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Clostridium novyi (strain NT)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A0Q2B3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A0Q2B3|HEM1_CLONN Glutamyl-tRNA reductase OS=Clostridium novyi (strain NT) OX=386415 GN=hemA PE=3 SV=1 MNLAVIGINYNNTPIDIREKVSFSKSQKYKACTYLIKKGISEIIIVSTCNRSEIYICSDEIDSHINEVVNFYKIFFNVESVNEYIFIKKDKEAVSHIYNVSAGLDSMILGEDQILGQVKEALRYSMENKFSRKVLNKLFREAITSAKKIKSELKISETPISMVYIAIKLLEKNIGTLKGKKACIIGAGDMGRLALKHLINEELEEIFVANRTYNNVIDLLKEFPKIKLIDYEKKYEILDNVDILITATAAPHLIIKKEQLQNIKQELYIMDLALPRDVEKSAGDIENIHLYDVDDFKNISDSNKIKREELSLIAKDSIDSYVNEFNQWMKSLKVDNTIKDLNNRCRDIKDEYLGYITKKIDLNERDKEILEKMLFGALKKVVKEPILNLKELKDEDEINKYIKSVNELFKF